Table 4 Prevalence (%) of the Pfcrt gene mutations by period in asymptomatic carriers and clinical cases
CVMNK | CVIET | SVMNT-like | SVMNT-like _CVMNK | CVMNK_CVIET | SVMNT-like_CVIET | CVMNK_SVMNT-like _CVIET | |
|---|---|---|---|---|---|---|---|
Asymptomatic carriers | |||||||
2005 (before ACT) (N = 42) | 12 (29) | 1 (2) | 7 (17) | 13 (31) | 0 (0) | 9 (21) | 0 (0) |
2007 (ACT implementation) (N = 67) | 1 (1) | 0 (0) | 0 (0) | 52 (78) | 7 (10) | 1 (1) | 6 (9) |
2008–2009 (ITNs implementation) (N = 16) | 0 (0) | 0 (0) | 8 (50) | 0 (0) | 0 (0) | 6 (38) | 2 (13) |
2010–2011 and 2013–2014 (malaria upsurges) (N = 28) | 1 (4) | 0 (0) | 0 (0) | 17 (61) | 0 (0) | 10 (36) | 0 (0) |
Symptomatic (clinical cases) | |||||||
2005 (before ACT) (N = 70) | 4 (6) | 2 (3) | 19 (27) | 0 (0) | 0 (0) | 44 (63) | 1 (1) |
2007 (ACT implementation) (N = 80) | 1 (1) | 0 (0) | 2 (3) | 4 (5) | 0 (0) | 68 (85) | 5 (6) |
2008–2009 (ITNs implementation) (N = 63) | 0 (0) | 0 (0) | 52 (83) | 1 (2) | 0 (0) | 10 (16) | 0 (0) |
2010–2011 and 2013–2014 (malaria upsurges) (N = 145) | 0 (0) | 0 (0) | 4 (3) | 50 (34) | 0 (0) | 87 (60) | 4 (3) |
All | |||||||
2005 (before ACT) (N = 112) | 16 (14) | 3 (3) | 26 (23) | 13 (12) | 0 (0) | 53 (47) | 1 (1) |
2007 (ACT implementation) (N = 147) | 2 (1) | 0 (0) | 2 (1) | 56 (38) | 7 (5) | 69 (47) | 11 (7) |
2008–2009 (ITNs implementation) (N = 79) | 0 (0) | 0 (0) | 60 (76) | 1 (1) | 0 (0) | 16 (20) | 2 (3) |
2010–2011 and 2013–2014 (malaria upsurges period) (N = 173) | 1(1) | 0(0) | 4(2) | 67(39) | 0(0) | 97(56) | 4(2) |